Balkrishna Industries Record Date Set for Interim Dividend Payment
Balkrishna Industries has announced the record date for the payment of the 2nd interim dividend for the financial year 2025-26. The record…
NTPC Limited Subsidiary NGEL Declares Commercial Operation of Wind Energy Capacity
NTPC Green Energy Limited (NGEL), a subsidiary of NTPC, has declared the commercial operation of a part capacity of 9.9 MW (Wind). This…
J. B. Chemicals & Pharmaceuticals Board Meeting to Approve Unaudited Financial Results
J. B. Chemicals & Pharmaceuticals has announced a board meeting scheduled for November 11, 2025. The purpose of the meeting is to…
Indian Energy Exchange Board Meeting Scheduled for October 30, 2025
Indian Energy Exchange (IEX) has announced a board meeting scheduled for October 30, 2025. The purpose of the meeting is to consider and…
Crompton Secures ₹445 Crore Solar Rooftop Project in Andhra Pradesh
Crompton Greaves Consumer Electricals has been awarded a project from New & Renewable Energy Development Corporation of Andhra Pradesh…
Steel Authority of India Limited (SAIL) Unaudited Financial Results for Quarter and Half Year Ended September 30, 2025
Steel Authority of India Limited (SAIL) will hold a board meeting on October 29, 2025, in New Delhi to consider and approve the unaudited…
Hindustan Petroleum Board to Consider Interim Dividend on October 29
Hindustan Petroleum Corporation Limited (HPCL) has announced that its Board of Directors will meet on October 29, 2025, to consider, among…
Dixon Technologies Q2 FY26 Revenue Up 29% to ₹14,858 Crore
Dixon Technologies announced a 29% increase in revenue to ₹14,858 crore for Q2 FY26. EBITDA grew by 34% to ₹564 crore, and PAT increased by…
UTI Asset Management Q2 FY26 Earnings Call Highlights Growth & Leadership Transition
UTI Asset Management Company Limited reported its Q2 and H1 FY26 earnings, highlighting an 11% AUM growth to ₹22.42 lakh crore. The Board has…
Ajanta Pharma Board to Consider Equity Dividend in Upcoming Meeting
The Board of Directors of Ajanta Pharma is scheduled to meet to consider an equity dividend. The meeting is set to take place on November 3,…